EVIO, Inc. (EVIO) Research
EVIO, Inc., along with its affiliates, provides specialized analytical testing and expert advisory services to the cannabis industry throughout the United States. The company's consulting expertise spans strategic guidance, product formulation assistance, and comprehensive support for licensing and regulatory compliance. Furthermore, EVIO conducts a full range of laboratory analyses, including cannabinoid potency assessment, terpene profiling, pesticide screening, residual solvent detection, visual inspections, and biological contaminant testing. The firm maintains its headquarters in Henderson, Nevada.
Market snapshot
- Symbol
- EVIO
- Price
- $0.00
- Day change
- 0.00%
- Market cap
- $959.7K
- P/E ratio
- 1.67x
- 52-week range
- 0.00001-0.0001
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
Peer companies
Recent insider activity
- Smith Anthony R. — A-Award (1820881 shares) on 2020-01-31
- Waldrop William — A-Award (3029007 shares) on 2020-01-31
- GLAUSER LORI JEAN — A-Award (2503650 shares) on 2020-01-31
- GLAUSER LORI JEAN — P-Purchase (7000 shares) on 2019-06-06
- GLAUSER LORI JEAN — P-Purchase (6000 shares) on 2017-11-10
Open EVIO, Inc. (EVIO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.